Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rhythm Pharmaceuticals Inc.

88.30
+3.073.60%
Post-market: 88.300.00000.00%19:43 EDT
Volume:666.99K
Turnover:58.31M
Market Cap:5.80B
PE:-31.32
High:88.42
Open:85.14
Low:84.39
Close:85.23
Loading ...

Pamela J. Cramer, Chief Human Resources Officer, Reports Disposal of Common Shares in Rhythm Pharmaceuticals Inc

Reuters
·
30 Jul

Rhythm Pharmaceuticals to Announce Second Quarter 2025 Financial Results

Reuters
·
23 Jul

BRIEF-Rhythm Pharmaceuticals Says Phase 2 Signal Trial Shows Bivamelagon Reduces BMI In Hypothalamic Obesity

Reuters
·
13 Jul

Rhythm Pharmaceuticals Unveils Promising Phase 3 Trial Results for Setmelanotide in Treating Acquired Hypothalamic Obesity at ENDO 2025

Reuters
·
13 Jul

CFO Hunter C. Smith Reports Disposal of Common Shares of Rhythm Pharmaceuticals Inc

Reuters
·
12 Jul

Rhythm Pharmaceuticals Raises $188.7 Million in Public Offering to Fund Clinical Development and Commercialization Efforts

Reuters
·
11 Jul

Citiznes JMP biotech analysts hold an analyst/industrry conference call

TIPRANKS
·
11 Jul

Rhythm Pharmaceuticals Is Maintained at Outperform by Oppenheimer

Dow Jones
·
11 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AbbVie, McDonald's

Reuters
·
11 Jul

Rhythm Pharmaceuticals (RYTM) Receives a Buy from Oppenheimer

TIPRANKS
·
10 Jul

Morgan Stanley Raises Price Target on Rhythm Pharmaceuticals to $95 From $80, Keeps Overweight Rating

MT Newswires Live
·
10 Jul

BRIEF-Rhythm Pharmaceuticals Announces Pricing Of Upsized Public Offering Of Common Stock

Reuters
·
10 Jul

Rhythm Pharmaceuticals resumed with a Buy at Goldman Sachs

TIPRANKS
·
10 Jul

BUZZ-Rhythm Pharma unveils $150 mln equity offering after stock soars

Reuters
·
10 Jul

Rhythm Pharmaceuticals Announces $150 Million Public Offering of Common Stock

Reuters
·
10 Jul

US Equity Markets Higher, Nasdaq Reaches New Record High Following Nvidia Milestone

MT Newswires Live
·
10 Jul

Sector Update: Health Care Stocks Softer Wednesday Afternoon

MT Newswires Live
·
10 Jul

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx

Reuters
·
10 Jul

Rhythm Pharmaceuticals price target raised to $95 from $73 at BofA

TIPRANKS
·
10 Jul

Rhythm Pharmaceuticals Up Nearly 31%, on Track for Record High Close -- Data Talk

Dow Jones
·
10 Jul